References
Matsuo K, Matsuzaki S, Nusbaum DJ, Ki S, Chang EJ, Klar M, Roman LD. Significance of malignant peritoneal cytology on survival of women with uterine sarcoma. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-09202-1.
El Husseiny G, Al Bareedy N, Mourad WA, et al. Prognostic factors and treatment modalities in uterine sarcoma. Am J Clin Oncol. 2002;25:256–60.
Yalman D, Ozsaran Z, Baltalarli B, Demir O, Ozdemir N, Aras A. Results of postoperative radiotherapy in the treatment of uterine sarcomas: a retrospective analysis of 46 patients. Eur J Gynaecol Oncol. 2008;29:46–51.
Matsuo K, Wright JD, Matsuzaki S, Roman LD, Harter P, Klar M. Malignant peritoneal cytology: areas of unmet need for evidence. Eur J Cancer. 2020. https://doi.org/10.1016/j.ejca.2020.08.004.
FIGO staging for uterine sarcomas. Int J Gynecol Obstet. 2009;104:179.
Acknowledgment
Koji Matsuo received support from the Ensign Endowment for Gynecologic Cancer Research.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Honorarium, Chugai, textbook editorial expense, Springer, and investigator meeting attendance expense, VBL therapeutics (K.M.); research funding, MSD (S.M.).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Matsuzaki, S., Matsuo, K. ASO Author Reflections: Spotlight on Malignant Peritoneal Cytology in Uterine Sarcoma: A Potential Avenue for Future Research. Ann Surg Oncol 28, 1749–1750 (2021). https://doi.org/10.1245/s10434-020-09255-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-020-09255-2